Company Email Format

Acrigen Biosciences

Biotechnology Research 1000 Atlantic Ave 6 employees

Employees: 6
Contacts: 3
Emails: 3
Phones: 2

acrigen.com LinkedIn Crunchbase

Acrigen Biosciences Overview

Headquarters: 1000 Atlantic Ave
Website: acrigen.com
Industry: Biotechnology Research
Employees: 6
Founded: 2019
Funding: 1.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Acrigen Biosciences

Acrigen Biosciences is an early-stage life science gene editing company based in Berkeley, California. We are building a pipeline of therapies to treat genetic disorders using our proprietary precision gene editing technology. Our technology utilizes novel CRISPR-Cas gene editors coupled with anti-CRISPR proteins to improve the precision, efficacy, and safety of genetic therapies. The company was co-founded in 2019 by Dr. Joseph Bondy-Denomy (Associate Professor at UCSF and discoverer of anti-CRISPR proteins) and Dr. David Rabuka (former Founder and CSO of Redwood Biosciences) with the mission of bringing precision genetic therapies to the clinic.

Acrigen Biosciences Contact Details

People in AeroLeads: 3
With contact data: 3
Email contacts: 3; 100.0% coverage
Phone contacts: 2; 66.7% coverage

Acrigen Biosciences Org Chart

Sample employees and titles

Name	Title	Location	Contact
Tandis Vazin, Phd	Genetic and Regenerative Medicine	San Francisco Bay Area, United States	Email Phone
Heath Lukatch		San Francisco, California, United States	Email
Joe Bondy-Denomy	Associate Professor at University	San Mateo, California, United States	Email Phone